Signify, Boston University validate effectiveness of Signify's UV-C light sources on inactivating virus.

LAHORE -- Signify (Euronext: LIGHT), the world leader in lighting, together with the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University in the US have conducted research that validates the effectiveness of Signify's UV-C light sources on the inactivation of SARS-CoV-2, the virus that causes COVID-19.

Since the start of the SARS CoV-2 pandemic, Dr Anthony Griffiths, Associate Professor of Microbiology at Boston University School of Medicine and his team have been working on developing tools to support scientific advancement in this field. During their research they have treated inoculated material with different doses of UV-C radiation coming from a Signify light source and assessed the inactivation capacity under various conditions...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT